Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
Pfizer raised its full-year adjusted profit forecast due to cost cuts and strong business performance, beating Q2 revenue estimates driven by Covid products and other drugs. The new profit guidance is $2.90 to $3.10 per share, up from $2.80 to $3.00, while maintaining its 2025 revenue outlook of $61 billion to $64 billion. The company plans to record a $1.35 billion one-time charge linked to … Continue reading Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
